Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gut feeling: probiotic may ease stress and anxiety

NCT ID NCT07216729

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily probiotic supplement (Lactobacillus reuteri) could lower stress, anxiety, and depressive symptoms in 150 adults aged 18-45 who reported feeling stressed. Participants took either the probiotic or a placebo for several weeks and completed surveys about their mood. The goal was to see if the probiotic helped them feel less stressed in the moment and over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Feb 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18 - 45 * scoring 14+ on the perceived stress scale-10 indicating medium stress or higher * ability to provide informed consent * willingness not to take probiotic supplements (pills, tablets, oils, etc.) other than the product provided in the clinical study until all study procedures are completed * own a smartphone and are willing to receive study materials and complete study procedures by text Exclusion Criteria: * a history of gastrointestinal discomfort or surgery, urinary incontinence, cancer, toxic shock syndrome, frequent diarrhea, vital signs outside of the acceptable range (i.e., blood pressure \>160/100, oral temperature \>100°F, pulse \>100), heart disease, heart attack, lung/respiratory disease, any pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality (i.e. a medical diagnosis related to lungs, heart, stomach/intestines, liver, or kidneys), HIV, Hepatitis B, Hepatitis C, bipolar disorder, psychosis, or confirmed or suspected immunosuppression or immunodeficiency * current (past month) alcohol or substance abuse or dependence (score of 2+ on the UNCOPE) * consistent (e.g., 5x/week or greater) probiotic supplementation within the last month, including probiotic food products such as yogurt * receiving antibiotics within the last month * receiving medications that interfere with gut motility (opiates, loperamide, stool softeners) * use of systemic antibiotics, antifungals, antivirals, or antiparasitics (intravenous, intramuscular, or oral) * use of oral, intravenous, intramuscular, nasal or inhaled corticosteroids * use of cytokines or cytokine inhibitors * use of methotrexate or immunosuppressive cytotoxic agents * receiving immunosuppressive drugs/medications or treatment including antineoplastic therapy, post-transplantation immunosuppressive therapy, and/or radiation therapy * participation in conflicting interventional research protocol * unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in their diet * female who is pregnant or lactating or reports expecting to get pregnant during the course of the study * currently involved in the criminal justice system as a prisoner or ward of the state

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Colorado Boulder, Muenzinger Psychology Building

    Boulder, Colorado, 80309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.